Seong Lin Teoh

Dr. Seong Lin Teoh

Universiti Kebangsaan Malaysia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IIIsma Liza Mohd Isa
Isma Liza Mohd Isa
STSeong Lin Teoh
Seong Lin Teoh
NNNurul Huda Mohd Nor
Nurul Huda Mohd Nor
SMSabarul Afian Mokhtar
Sabarul Afian Mokhtar
Intervertebral disc (IVD) degeneration is a major contributing factor for discogenic low back pain (LBP), causing a significant global disability. The IVD consists of an inner core proteoglycan-rich nucleus pulposus (NP) and outer lamellae collagen-rich annulus fibrosus (AF) and is confined by a cartilage end plate (CEP), providing structural support and shock absorption against mechanical loads. Changes to degenerative cascades in the IVD cause dysfunction and instability in the lumbar spine. Various treatments include pharmacological, rehabilitation or surgical interventions that aim to relieve pain; however, these modalities do not halt the pathologic events of disc degeneration or promote tissue regeneration. Loss of stem and progenitor markers, imbalance of the extracellular matrix (ECM), increase of inflammation, sensory hyperinnervation and vascularization, and associated signaling pathways have been identified as the onset and progression of disc degeneration. To better understand the pain originating from IVD, our review focuses on the anatomy of IVD and the pathophysiology of disc degeneration that contribute to the development of discogenic pain. We highlight the key mechanisms and associated signaling pathways underlying disc degeneration causing discogenic back pain, current clinical treatments, clinical perspective and directions of future therapies. Our review comprehensively provides a better understanding of healthy IVD and degenerative events of the IVD associated with discogenic pain, which helps to model painful disc degeneration as a therapeutic platform and to identify signaling pathways as therapeutic targets for the future treatment of discogenic pain.

1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NRNorhashima Abd Rashid
Norhashima Abd Rashid
SHSyarifah Aisyah Syed Abd Halim
Syarifah Aisyah Syed Abd Halim
STSeong Lin Teoh
Seong Lin Teoh
Siti Balkis BudinSiti Balkis Budin
Siti Balkis Budin
FHFarida Hussan
Farida Hussan
NJNahdia Afiifah Abdul Jalil
Nahdia Afiifah Abdul Jalil
Cisplatin is a potent platinum-based anticancer drug approved by the Food Drug Administration (FDA) in 1978. Despite its advantages against solid tumors, cisplatin confers toxicity to various tissues that limit its clinical uses. In cisplatin-induced hepatotoxicity, few mechanisms have been identified, which started as excess generation of reactive oxygen species that leads to oxidative stress, inflammation, DNA damage and apoptosis in the liver. Various natural products, plant extracts and oil rich in flavonoids, terpenoids, polyphenols, and phenolic acids were able to minimize oxidative stress by restoring the level of antioxidant enzymes and acting as an anti-inflammatory agent. Likewise, treatment with honey and royal jelly was demonstrated to decrease serum transaminases and scavenge free radicals in the liver after cisplatin administration. Medicinal properties of these natural products have a promising potential as a complementary therapy to counteract cisplatin-induced hepatotoxicity. This review concentrated on the protective role of several natural products, which has been proven in the laboratory findings to combat cisplatin-induced hepatotoxicity.

9 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NMNellysha Namela binti M.A.K
Nellysha Namela binti M.A.K
FAFairus Ahmad
Fairus Ahmad
STSeong Lin Teoh
Seong Lin Teoh
Mohamad Fairuz YahayaMohamad Fairuz Yahaya
Mohamad Fairuz Yahaya
Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered high-density lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that could lead to full-blown diabetes, heart disease, and many others. With increasing sedentary lifestyles, coupled with the current COVID-19 pandemic, the numbers of people affected with MetS will be expected to grow in the coming years. While keeping these factors checked with the polypharmacy available currently, there is no single strategy that can halt or minimize the effect of MetS to patients. This opens the door for a more natural way of controlling the disease. Caffeic acid (CA) is a phytonutrient belonging to the flavonoids that can be found in abundance in plants, fruits, and vegetables. CA possesses a wide range of beneficial properties from antioxidant, immunomodulatory, antimicrobial, neuroprotective, antianxiolytic, antiproliferative, and anti-inflammatory activities. This review discusses the current discovery of the effect of CA against MetS.

28 February 2018 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
JKJaya Kumar
Jaya Kumar
SDSrijit Das
Srijit Das
STSeong Lin Teoh
Seong Lin Teoh
Acrylamide (AA) is a water-soluble white crystalline solid commonly used in industries. It was listed as an industrial chemical with potential carcinogenic properties. However to date, AA was used to produce polyacrylamide polymer, which was widely used as a coagulant in water treatment; additives during papermaking; grouting material for dams, tunnels and other underground building constructions. AA in food could be formed during high-temperature cooking via several mechanisms, i.e. formation via acrylic acid which may be derived from the degradation of lipid, carbohydrates or free amino acids; formation via the dehydration/decarboxylation of organic acids (malic acid, lactic acid and citric acid); and direct formation from amino acids. The big debate is whether this compound is toxic to human beings or not. In the present review, we discuss the formation of AA in food products, its consumption and possible link to the development of any cancers. We discuss the body enzymatic influence on AA and mechanism of action of AA on hormone, calcium signaling pathways and cytoskeletal filaments. We also highlight the deleterious effects of AA on nervous system, reproductive system, immune system and the liver. The present and future mitigation strategies are also discussed. The present review on AA may be beneficial for researchers, food industry and also medical personnel.

30 April 2021 in Frontiers in Neuroscience
Verified
Journal Article
Open access
YPYong Hui Nies, PhD
Yong Hui Nies, PhD
NNNor Haliza Mohamad Najib
Nor Haliza Mohamad Najib
WLWei Ling Lim
Wei Ling Lim
MKMohd Amir Kamaruzzaman
Mohd Amir Kamaruzzaman
MYMohamad Fairuz Yahaya
Mohamad Fairuz Yahaya
STSeong Lin Teoh
Seong Lin Teoh
Parkinson’s disease (PD) is a severely debilitating neurodegenerative disease, affecting the motor system, leading to resting tremor, cogwheel rigidity, bradykinesia, walking and gait difficulties, and postural instability. The severe loss of dopaminergic neurons in the substantia nigra pars compacta causes striatal dopamine deficiency and the presence of Lewy bodies indicates a pathological hallmark of PD. Although the current treatment of PD aims to preserve dopaminergic neurons or to replace dopamine depletion in the brain, it is notable that complete recovery from the disease is yet to be achieved. Given the complexity and multisystem effects of PD, the underlying mechanisms of PD pathogenesis are yet to be elucidated. The advancement of medical technologies has given some insights in understanding the mechanism and potential treatment of PD with a special interest in the role of microRNAs (miRNAs) to unravel the pathophysiology of PD. In PD patients, it was found that striatal brain tissue and dopaminergic neurons from the substantia nigra demonstrated dysregulated miRNAs expression profiles. Hence, dysregulation of miRNAs may contribute to the pathogenesis of PD through modulation of PD-associated gene and protein expression. This review will discuss recent findings on PD-associated miRNAs dysregulation, from the regulation of PD-associated genes, dopaminergic neuron survival, α-synuclein-induced inflammation and circulating miRNAs. The next section of this review also provides an update on the potential uses of miRNAs as diagnostic biomarkers and therapeutic tools for PD.

14 February 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
ASAmro M. Soliman
Amro M. Soliman
SDSrijit Das
Srijit Das
NGNorzana Abd Ghafar
Norzana Abd Ghafar
STSeong Lin Teoh
Seong Lin Teoh
Wound healing is a complex biological process that is generally composed of four phases: hemostasis, inflammation, proliferation, and remodeling. The proliferation phase is crucial for effective healing compared to other phases. Many critical events occur during this phase, i.e., migration of fibroblasts, re-epithelialization, angiogenesis and wound contraction. Chronic wounds are common and are considered a major public health problem. Therefore, there is the increasing need to discover new therapeutic strategies. MicroRNA (miRNA) research in the field of wound healing is in its early phase, but the knowledge of the recent discoveries is essential for developing effective therapies for the treatment of chronic wounds. In this review, we focused on recently discovered miRNAs which are involved in the proliferation phase of wound healing in the past few years and their role in wound healing.